pyrrolidonecarboxylic acid has been researched along with MS (Multiple Sclerosis) in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hyun, JS; Jeong, IH; Kim, HH; Kim, HJ; Kong, BS; Park, SJ | 1 |
| Gwirtsman, H; Hershman, JM; Pekary, AE; Smith, VP; Tourtellotte, WW | 1 |
2 other study(ies) available for pyrrolidonecarboxylic acid and MS (Multiple Sclerosis)
| Article | Year |
|---|---|
Metabolomic profiling of CSF in multiple sclerosis and neuromyelitis optica spectrum disorder by nuclear magnetic resonance.
Topics: Acetates; Acetone; Adolescent; Adult; Aged; Child; Citric Acid; Female; Formates; Glucose; Humans; Hydroxybutyrates; Lactic Acid; Magnetic Resonance Spectroscopy; Male; Metabolome; Metabolomics; Middle Aged; Multiple Sclerosis; Multivariate Analysis; Neuromyelitis Optica; Proton Magnetic Resonance Spectroscopy; Pyrrolidonecarboxylic Acid; Young Adult | 2017 |
High levels of thyrotropin-releasing hormone precursor peptide immunoreactivity and binding substance occur in human cerebrospinal fluid.
Topics: Alzheimer Disease; Amino Acid Sequence; Chromatography, High Pressure Liquid; Humans; Molecular Sequence Data; Multiple Sclerosis; Protein Precursors; Pyrrolidonecarboxylic Acid; Thyrotropin-Releasing Hormone | 1991 |